Medicare Enrolled

Dr. David Levin, MD

Cytopathology Physician · Fremont, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
2000 MOWRY AVE, Fremont, CA 94538
5107971111
In practice since 2006 (20 years)
NPI: 1780646364 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Levin

Dr. David Levin is a cytopathology physician in Fremont, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Levin performed 1,489 Medicare services across 996 unique beneficiaries.

Between the years covered by Open Payments, Dr. Levin received a total of $408 from 6 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Levin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 40% volume in CA $408 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,489
Medicare services
Top 40% in CA for cytopathology physician
996
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~74 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
433 $33 $199
Blood smear interpretation with written report
A physician examines a blood sample slide under a microscope to analyze blood cells. The doctor provides a written report of their findings.
213 $21 $60
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
196 $25 $66
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
153 $31 $122
Manual microscopic genetic analysis of tumor
A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes.
89 $37 $270
Moderately high complexity pathology tissue examination
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation.
76 $74 $273
Tissue preparation to remove calcium
A laboratory procedure that removes calcium from a tissue sample to prepare it for microscopic examination.
67 $11 $35
Cell examination with selective cellular enhancement
A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis.
59 $24 $180
Special tissue stain and interpretation
A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings.
56 $11 $60
Pathology tissue examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis.
50 $10 $131
Computer-assisted genetic tissue analysis
A microscopic genetic analysis of tissue using computer-assisted technology for the initial multiplex procedure.
30 $38 $150
Intraoperative pathology examination of specimen
A pathology test performed during surgery to examine a tissue sample from the initial site. The results help guide the surgeon's immediate decisions.
20 $56 $160
Flow cytometry, 16 or more markers
A laboratory test that uses lasers to analyze cells or DNA using 16 or more different markers. This technique helps identify and characterize specific cell types based on their physical and chemical properties.
18 $75 $280
Bone marrow smear interpretation
A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities.
16 $42 $200
Intraoperative pathology exam, additional site
A microscopic examination of tissue samples performed during surgery to check for disease. This code applies to each additional site examined beyond the first.
13 $34 $85
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$408
Total received (2018-2022)
Avg $136/year across 3 years
Top 21% in CA for cytopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
6
Companies
7
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$408 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$154
2019
$36
2018
$218

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$135
Roche Diagnostics Corporation
$19
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
AstraZeneca Pharmaceuticals LP
$244
Microgenics Corporation
$63
Genentech USA, Inc.
$36
Foundation Medicine, Inc.
$32
Roche Diagnostics Corporation
$19
Abbott Laboratories
$13
Top 3 companies account for 84.1% of all-time payments
Associated products mentioned in payments ›
Architect system · ENHERTU · FOUNDATIONONE · Procalcitonin (PCT) · cobas pro ISE analytical unit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cytopathology physician in Fremont?
Compare cytopathology physicians in the Fremont area by procedure volume, costs, and industry payment transparency.
Browse cytopathology physicians nearby

Geographic Context

Cytopathology physicians within 10 mi
26
Per 100K population
1.6
County median income
$126,240
Nearest hospital
WASHINGTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Levin is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Levin experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Levin performed 433 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levin receive payments from pharmaceutical companies?
Yes. Dr. Levin received a total of $408 from 6 companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levin's costs compare to other cytopathology physicians in Fremont?
Dr. Levin's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →